#Ipo moneycontrol series#

On September 20, Moneycontrol reported that Dr Azaad Moopen-led healthcare conglomerate Aster DM Healthcare had roped in Moelis and Credit Suisse as advisors to unlock value via an internal rejig exercise, which would involve splitting its Middle East and India business.

Here’s a snapshot of all the M&A action in the segment since the beginning of the year which has been closely tracked by Moneycontrol: The domestic hospital space has been buzzing with deal activity as the economy gradually recovers from the impact of Covid-19. HOSPITAL M&A IN THE PINK OF HEALTH AND CHEER! In August 2022, Dilip Jose, MD & CEO of Manipal Hospitals, told the Times of India that the firm was planning more acquisitions in locations like NCR, Kerala and Hyderabad. In November 2020, it acquired the Indian assets of Columbia Asia Hospitals for around Rs 2,100 crore and later in June 2021, it purchased Bengaluru based Vikram Hospitals from Multiple Private Equity for around Rs 350 crore.Īccording to reports, it is also believed to be close to acquiring the AMRI Hospital chain in Kolkata from the Emami Group. The Manipal group, which has nearly 8,000 beds across 28 hospitals, is expected to pursue a listing on Dalal Street in the next 1-2 years and has been on a consolidation drive. Singapore’s Temasek owns an 18 percent stake, NIIF ( National Infrastructure Investment Fund) holds 8 per cent while the remaining is held by the promoter family.Īs part of its India portfolio, TPG also backs Care Hospitals, Motherhood hospitals, and infertility chain Nova IVF.īack in January 2022, Moneycontrol was the first to report that nearly three years after taking over the management of hospitals and clinics previously managed by a fund of failed private equity firm Abraaj, TPG-backed Evercare was looking to exit Hyderabad based Care Hospitals. The leading global investment firm holds around 21 per cent stake.

TPG Capital picked up a significant minority stake in the Ranjan Pai led hospital chain for Rs 900 crore in February 2015. In the domestic healthcare and pharma space, KKR also backs listed firm JB Chemicals and Pharmaceuticals. Later, KKR also sold an additional 10 percent in Max Healthcare for nearly Rs 3,300 crore in March.

In September 2021, KKR sold 84.4 million shares of Max Healthcare for Rs 2,956 crore via the block deal route. In 2018, KKR acquired shares in Max Healthcare along with Radiant Life Care. Soi has now become the sole promoter after the US private equity firm’s exit. Max Healthcare Chairman and Managing Director Abhay Soi (who held 23.09 per cent stake as of the quarter ending June 2022) and KKR were earlier co-promoters of the firm.

Unlocking opportunities in Metal and Mining.

#Ipo moneycontrol series#

Interview Series Business In The Week Ahead.